Antisense peptides: A critical mini-review

Journal of Theoretical Biology

Volumn 190, Issue 2, 1998, Pages 107-119

  Root Bernstein, Robert S ^a   Holsworth, Daniel D ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; PEPTIDE;

PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW;

EID: 0032554117     PISSN: 00225193     EISSN: None     Source Type: Journal    
DOI: 10.1006/jtbi.1997.0544     Document Type: Article

References (97)

1. AL-OBEIDI, F. A., HRUBY, V. J., SHARMA, S. D., HADLEY, M. E. & CASTRUCCI, A. M. (1990). Antisense peptides of the melanocyte-stimulati hormone (MSH): surprising results, In: Peptides. Chemistry, Structure and Biology (Rivier, J. E. & Marshall, G. R., eds), pp. 530-532. Leiden: ESCO.
2. BARANYI, L., CAMPBELL, W., OHSHIMA, K., FUJIMOTO, S., BOROS, M. & OKADA, H. (1995). The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nature Med. 1, 894-901.
3. BIRO, J. (1981). Comparative analyses of specificity in protein-protein interactions. Part II. The complementary coding of some proteins as a possible source of specificity in protein-protein interactions. Med. Hypoth. 7, 981-993.
4. BLALOCK, J. E. (1995). Genetic origins of protein shape and interaction rules. Nature Med. 1, 1222-1223.
5. BLALOCK, J. E. & SMITH, E. M. (1984). Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem. Biophys. Res. Commun. 121, 203-207.
6. BLALOCK, J. E. & BOST, K. L. (1986). Binding of peptides that are specified by complementary RNAs. Biochem. J. 234, 679-683.
7. BLALOCK, J. E. & BOST, K. L. (1988a). Ligand receptor characteristics of peptides encoded by complementary nucleic acids: implications for a molecular recognition code. Recent Progress in Hormone Res. 44, 199-215.
8. BLALOCK, J. E., OPARIL, S., BOST, K. L., DION, D. L. & ELTON, T. S. (1988b). Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc. Natl. Acad. Sci. U.S.A. 85, 2518-2522.
9. BLALOCK, J. E. & BOST, K. L. (1989). Preparation and use of complementary peptides. Chap. 3. Methods in Enzymology 168, 16-28.
10. BOROVSKY, D., POWELL, C. A., NAJAR, J. K., BLALOCK, J. E. & HAYS, T. K. (1994). Characterization and localization of mosquito g receptors for trypsin modulating oostatic factor using a complementary peptide and immunochemistry. FASEB J. 8, 350-355.
11. BOST, K. L., SMITH, E. M. & BLALOCK, J. E. (1985a). Similarities between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc. Natl. Acad. Sci. U.S.A. 82, 1372-1375.
12. BOST, K. L., SMITH, E. M. & BLALOCK, J. E. (1985b). Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin 2 and their respective receptors. #2Biochem. Biophys. Res. Commun. 128, 1373-1380.
13. BOST, K. L. & BLALOCK, J. E. (1986). Molecular characterization of a corticotrophin (ACTH) receptor. Mol. Cell. Endocrinol. 44, 1-9.
14. BOST, K. L. & BLALOCK, J. E. (1989). Complementary peptides as interactive sites for protein binding. Viral Immunol. 2, 229-238.
15. BRENTANI, R. B. (1988). Biological implications of complementary hydropathy of amino acids. J. theor. Biol. 135, 495-499.
16. BUDISAVLJEVIC, M., BEA, M. L., BENSOUSSAN, M., LAUBIE, M., CHUONG, P. P. V., DUSSAULE, J. C., VERROUST, P. J. & RONCO, P. M. (1992). Antagonist effect of a receptor-mimicking peptide encoded by human angiotensin II complementary RNA. Hypertension 19, 345-354.
17. CARR, D. J., BOST, K. L. & BLALOCK, J. E. (1986). An antibody to a peptide specified by a RNA that is complementary to gamma-endorphin RNA recognizes an opiate receptor. J. Neuroimmunol. 12, 329-337.
18. CHAIKEN, I. M., ABERCROMBIE, D. M., KANMERA, T. & SEQUEIRA, R. P. (1983). Neuronal peptide-protein complexes: neurophysins and associated neuropeptide hormones. Pept. Protein Rev. 1, 139-209.
19. CLARKE, B. L. & BLALOCK, J. E. (1991). Antisense Nucleic Acids and Proteins: Fundamentals and Applications (Kkrol, V.-D., ed.), pp. 169-185, New York: Marcel Dekker, Inc.
20. CURTO, E. V. & KRISHNA, N. R. (1994). Nuclear magnetic resonance studies on complementary peptides. Immunomethods 5, 98-106.
21. DE BENEDETTI, P. G., COCCHI, M. & MENZIANI, M. C. (1993). A molecular dynamics simulation of sequence directed recognition peptides intereacting with bigendothelin. J. Mol. Stucture 286, 95-108.
22. DE GASPARO, M. S., WHITEBREAD, S., EINSLE, K. & HEUSSER, C. (1989). Are the antibodies to a peptide complementary to angiotensin II useful to isolate the angiotensin II receptor? Biochem. J. 261, 310-311.
23. DILLON, J., WOODS, W. T., GUARCELLO, V., LE BOEUF, R. D. & BLALOCK, J. E. (1991). A peptide mimetic of calcium. Proc. Natl. Acad. Sci. U.S.A. 88, 9726-9729.
24. DILLON, P. F., WEBERLING, M. K., LETART, S. M., CLARK, J. F., SEARS, P. R. & ROOT-BERNSTEIN, R. S. (1995). Creatine kinase increases the solubility and enzymatic activity of pyruvate kinease by means of daizymatic coupling. J. Biol. Physics 21, 11-23.
25. DILLON, P. F., ROOT-BERNSTEIN, R. S. & HOLSWORTH, D. D. (1998). Augmentation of aortic ring contractions by angiotensin II antisense peptide. Hypertension (in press).
26. EATON, H. L., FEISK, S. W., AUSTIN, R. E. & MARTIN, S. F. (1989). NMR study of the possible interactions in solution of angiotensin II with a peptide encoded by angiotensin II complementary RNA. Proc. Natl. Acad. Sci. U.S.A. 86, 9767-9769.
27. EBERLE, A. N. & HUBER, M. (1991). Antisense peptides of ACTH and MSH: tools for receptor isolation? In: Antisense Nucleic Acids and Proteins, Fundementals and Applications (Mol, N. M. J. & Krol, R. V.-D., eds), pp. 187-203. New York: Marcel Dekker, Inc.
28. ELTON, T. S., DION, L. D., BOST, K. L., OPARIL, S. & BLALOCK, J. E. (1988). Purification of an angiotensin II binding protein using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc. Natl. Acad. Sci. U.S.A. 85, 2518-2522.
29. FASSINA, G., ZAMAI, M., BRIGHAM-BURKE, M. & CHAIKEN, I. M. (1989). Recognition properties of antisense peptides to Arg8-vasopressin/bovine neurophysin II biosynthetic precursor sequences. Biochemistry 28, 8811-8818.
30. FASSINA, G., CONSONNI, R., ZETTA, L. & CASSANI, G. (1992). Design of hydropathically complementary peptides for big endothelin affinity purification. Int. J. Pept. Protein Res. 39, 540-548.
31. FASSINA, G. (1994). Complementary peptides as antibody mimetics for protein purification and assay. Immunomethods, 5, 121-129.
32. FUKUCHI, S. & OTSUKA, J. (1992). Evolution of metabolic pathways by chance assembly of enzyme proteins generated from sense and antisense strands of pre-existing genes. J. theor. Biol. 158, 271-291.
33. GARTNER, T. K. & TAYLOR, D. B. (1990). The amino acid sequence Gly-Ala-Pro-Leu appears to be a fibrinogen binding site in the platelet integrin, glycoprotein IIb. Thromb. Res. 60, 291-309.
34. GARTNER, T. K. & TAYLOR, D. B. (1991). The peptide Glu-His-Ile-Pro-Ala binds fibrinogen and inhibits platelet aggregation and adhesion to fibrinogen and vitronectin. Proc. Soc. Exp. Biol. Med. 198, 649-655.
35. GARTNER, T. K., LOUDON, R. & TAYLOR, D. B. (1991). The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of the fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem. Biophys. Res. Commun. 180, 1446-1452.
36. GARTNER, T. K., TAYLOR, D. B. & DERRICK, J. (1994). Complementary peptides that interfere with platelet aggregation and adherence. Immunomethods 5, 148-157.
37. GIBSON, I. (1994). Antisense DNA and RNA strategies: New approaches to therapy. J. Roy. Physicians Lond. 28(6), 507-511.
38. GILBERT, W. (1978). Why genes in pieces? Nature (London) 271, 501-504.
39. GOLDSTEIN, A. & BRUTLAG, D. L. (1989). Is there a relationship between DNA sequences encoding peptide ligands and their receptors? Proc. Natl. Acad. Sci. U.S.A. 86, 42-45.
40. GORCS, T. J., GOTTSCHALL, P. E., COY, D. H. & ARIMURA, A. (1986). Possible recognition of the GnRH receptor by an antiserum against peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide. Peptides 7, 1137-1145.
41. GRAFSTEIN, D. (1983). Stereochemical origins of the genetic code. J. theor. Biol. 105, 157-174.
42. GUILLEMETE, G., BOULAY, G., GAGNON, S., BOSSE, R. & ESCHER, E. (1989). The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. Biochem. J. 261, 309.
43. HOLSWORTH, D. D., KIELY, J. S., ROOT-BERNSTEIN, R. S. & OVERHISER, R. W. (1994). Antisense peptides: A comparative study focusing on angiotensin II antagonists. Peptide Res. 7, 185-193.
44. HRUBY, V. J., SHARMA, S. D., COLLINS, N., MATSUNAGA, T. O. & RUSSEL, K. C. (1992). Applications of synthetic peptides. In: Synthetic Peptides. A Users Guide (Orant, G. A., ed.), pp. 259-345. New York: Freeman.
45. ILDIS, R. G. (1980). The principle of cross-stereocomplementarity and the symmetry of the genetic code. Mendeleev Chemistry J. 25, 126-131.
46. JACKSON, E. K., PRAKASH, C. & BLAIR, I. A. (1993). Studies on the peptides encoded by rat and human angiotensin II complementary RNA. Hypertension 21, 42-49.
47. JARPE, J. A. & BLALOCK, J. E. (1994). Complementary peptides: applications of the molecular recognition theory to peptide and protein purification and design. In: Peptides: Design, Synthesis and Biological Activity (Basava, C. & Anantharamaiah, G. M., eds) Boston: Birkehauser.
48. JOHNSON, H. M. & TORRES, B. A. (1988). A novel arginine vasopressin-binding peptide that blocks arginine vasopressin modulation of immuno function. J. Immunol. 141, 2420-2423.
49. JOHNSON, H. M. & TORRES, B. A. (1994). Complementary peptides as probes to explore neuropeptide receptors on lymphocytes. Immunomethods 5, 167-171.
50. JONES, D. S. (1972). Polypeptides. Part XIII. Peptides related to the C-terminal tetrapeptide sequence of gastrins by complementary reading of the genetic message. J. Chem. Soc. Perkin 1, 1407-1415.
51. JURZAK, M., PAVO, I. & FHARENHOLZ, F. (1993). Lack of interaction of vasopressin with its antisense peptides: a functional and immunological study. J. Receptor Res. 13, 881-902.
52. KAISER, E. T. & KEZDY, F. J. (1984). Amphiphilic secondary structure: design of peptide hormones. Science 223, 249-255.
53. KELLY, J. M., TRINDER, D., PHILLIPS, P. A., CASTLEY, D. J., KEMP, B., MOSER, V. & JOHNSTON, E. I. (1990). Vasopressin antsense peptide interactions with the VI receptor. Peptides 11, 857-862.
54. KNUTSON, V. P. (1988). Insulin-binding peptide. Design and characteristics. J. Biol. Chem. 263, 14146-14151.
55. KUNISAWA, T. & OTSUKA, J. (1987) A possible mode of protein evolution. Role of anti-sense strand in the generation of new protein. Protein Seq. Data Anal. 1, 117-121.
56. KYTE, J. & DOOLITTLE, R. F. (1982). A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157, 105-132.
57. LOO, J. A., HOLSWORTH, D. D. & ROOT-BERNSTEIN, R. S. (1994). Use of electrospray ionization mass spectroscopy to probe antisense peptide interactions. Biol. Mass Spectroscopy 23, 6-12.
58. LU, F. X., AIYAR, N. & CHAIKEN, I. (1991) Affinity capture of [Arg8] vasopressin-receptor complex using immobilized antisense peptides. Proc. Natl. Acad. Sci. U.S.A. 88, 3642-3646.
59. LUNDGREN, O., HAGLIND, E. & MARDH, S. (1989). Failure to deduce a peptide inhibityor of Na, K-ATPase from the gene coding for the catalytic alpha-subunit of Na, K-ATPase. Acta Physiol. Scand. 136, 281-286.
60. MARKUS, G., TRITSCH, G. L. & PARTHASARATHY, R. (1989). A model for hydropathy-based peptide interactions. Arch. Biochem. Biophys. 272, 433-439.
61. MARTIN, S. F., FEISK, S. W., AUSTIN, R. E. & EATON, H. L. (1989). NMR study of the possible interactions in solution of angiotensin II with a peptide encoded by angiotensin II complementary RNA. Proc. Natl. Acad. Scis. U.S.A. 86, 9767-9769.
62. MARTIN-MOE, S. A., LEHR, R., CAULEY, M. D. & MOE, G. R. (1995). Hydrophobic interactions and the design of receptor mimetic peptides. Peptide Res. 8, 70-76.
63. MCGUIGAN, J. E. & CAMPBELL-THOMPSON, M. (1992). Complementary peptide to the carboxyl terminal tetrapeptide of gastrin. Gastroenterology 103, 749-758.
64. MEKLER, L. B. (1969). On the specific selective interaction between amino acid residues of polypeptide chain. Biofizika 14, 581-584.
65. MEKLER, L. B. & ILDIS, R. G. (1981). Construction of models of three-dimensional biological polypeptide and nucleoprotein molecules in agreement with a general code which determines specific linear recognition and binding of amino acid residues of polypeptides to each other and to the trinucleoties of polynucleotides. Deposited document VINITI 1476-81. (In Russian).
66. MISRA, P. K., HAQ, W., KATTI, S. B., MATHUR, K. B., RAGHUBIR, R., PATNAIK, G. K. & DHAWAN, B. N. (1993). Enkephalin antisense peptides: design, synthesis, and biological activity. Pharmaceutical Res. 10, 660-661.
67. MOORE, G. J., GANTER, R. C. & FRANKLIN, K. J. (1989). Angiotensin "antipeptide": (-) messenger RNA complementary to human angiotensin II (+) messenger RNA encodes an angiotensin receptor antagonist. Biochem. Biophys. Res. Commun. 160, 1387-1391.
68. MULCHAHEY, J. J., NEILL, J. D., DION, L. D., BOST, K. L. & BLALOCK, J. E. (1986). Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH. Proc. Natl. Acad. Sci. U.S.A. 83, 9714-9718.
69. NAJEM, E. S., CORIGLIANO-MURPHY, A. & FERRETTI, J. A. (1989). Conformational behavior of fragments of adrenocorticotropin and their antisense peptides determined by NMR spectroscopy and CD spectropolarimetry. FEBS Lett. 250, 405-410.
70. NECKERS, L. & WHITESELL, L. (1993). Antisense technology: Biological utility and practical considerations. Am. J. Physiol. 265(1 Pt1), L1-L12.
71. NEMETHY, G. & SCHERAGA, H. A. (1962). The structure of water and hydrophobic bonds in proteins III. The thermodynamic properties of hydrophobic bonds in proteins. J. Phys. Chem. 66, 1773-1789.
72. OKADA, H., BOROS, M., FUJIMOTO, S., OHSHIMA, K., CAMPBELL, W. & BARANYI, L. (1995). The antisense homology box: A new motif within proteins that encodes biologically active peptides. Nature Med. 1, 894-901.
73. ORTS, R. J., BRUOT, B. C. & SARTIN, J. L. (1980a). Inhibitory properties of a bovine pineal tripeptide, thryonylseryllysine, on serum follicle-stimulating hormone. Neuroendocrinology 31, 92-95.
74. ORTS, R. J., LIAO, T.-H., SARTIN, J. L. & BRUOT, B. C. (1980b). Isolation, purification and amino acid sequence of a tripeptide from bovine pineal tissue displaying antigonadotropic properties. Biochim. Biiophys. Acta 628, 201-208.
75. PASQUALINI, R., CHAMONE, D. F. & BRENTANI, R. R. (1989). Determination of the putative binding site for fibronectin on platelet glycoprotein IIb-IIIa complex through a hydropathic complementarity approach. J. Biol. Chem. 264, 14566-14570.
76. RAETZ, C. R. & RODERICK, S. L. (1995) A left-handed parallel beta helix in the structure of UDP-N-acetylglucosamine acetyl transferase. Science 270, 997-1000.
77. RASMUSSEN, U. B. & HESCH, H. D. (1987). On antisense peptides: the parathyroid horone as an experimental example and a critical theoretical view. Biochem. Biophys. Res. Commun. 149, 930-938.
78. ROOT-BERNSTEIN, R. S. (1982a). Amino acid pairing. J. theor. Biol. 94, 885-894.
79. ROOT-BERNSTEIN, R. S. (1982b). On the origin of the genetic code. J. theor. Biol. 94, 895-904.
80. ROOT-BERNSTEIN, R. S. (1983). Protein replication by amino acid pairing. J. theor. Biol. 100, 99-106.
81. ROOT-BERNSTEIN, R. S. (1984). Molecular sandwiches as a basis for structural and functional similarities of interferon's, MSH, ACTH, LHRH, Myelin Basic Protein and Albumins. FEBS Lett. 168, 208-212.
82. ROOT-BERNSTEIN, R. S. & WESTALL, F. C. (1984a). Serotonin binding sites. I. Structures of sites on Myelin Basic Protein, LHRH, MSH, and ACTH. Brain Res. Bull. 12, 425-436.
83. ROOT-BERNSTEIN, R. S. & WESTALL, F. C. (1984b). Fibrinopeptide A binds Gly Pro Arg Pro. Proc. Natl. Acad. Sci. U.S.A. 81, 4339-4342.
84. ROOT-BERNSTEIN, R. S. & WESTALL, F. C. (1986). Bovine pineal antireproductive tripeptide bindK to luteninazing hormone releaging hormone: a model for peptide modulation by sequence specific peptide interaction? Brain Res. Bull. 17, 519-528.
85. ROOT-BERNSTEIN, R. S. (1987). Catecholamines bind to enkephalins, morphiceptin, and morphine. Brain Res. Bull. 18, 509-532.
86. ROOT-BERNSTEIN, R. S. & WESTALL, F. C. (1990). Serotonin binding sites. II. Muramyl dipeptides bind to serotonin binding sites on myelin basic protein, LHRH, MSH, and ACTH. Brain Res. Bull. 25, 827-841.
87. RUIZ-OPAZO, N., AKIMOTO, K. & HERRERA, V. L. (1995) Identification of a novel dual angioitensin II/vasopressin receptor on the basis of molecular recognition theory. Nat. Med. 1, 1074-1081.
88. SEGERSTEEN, U., NORDGREN, H. & BIRO, J. C. (1986). Frequent occurrence of short complementary sequences in nucleic acids. Biochem. Biophys. Res. Commun. 139, 94-101.
89. SHAI, Y., FLASHNER, M. & CHAIKEN, I. M. (1987). Antisense peptide recognition of sense peptides: Direct quantative characterization with the ribonuclease S-peptide system using analytical high performance affinity chromatography. Biochemistry 26, 669-675.
90. SHAI, Y., BRUNCK, T. K. & CHAIKEN, I. M. (1989). Antisense peptide recognition of sense peptides: sequence simplification and evaluation of forces underlying the interaction. Biochemistry 28, 8804-8811.
91. SMITH, C. K. & REGAN, L. (1995) Guidelines for protein design: the energetics of beta sheet side chain interactions. Science 270, 980-982.
92. SOFFER, R. L., BANDYOPADHYAY, S., ROSENBERG, E., HOEPRICH, P., TEITELBAUM, A., BRUNCK, T., COLBY, C. B. & GLOFF, C. (1987). Unexpected binding of an octapeptide to angiotensin II receptor. Proc. Natl. Acad. Sci. U.S.A. 84, 9219-9222.
93. TROPSHA, A., KIZER, J. S. & CHAIKEN, I. M. (1992). Making sense from antisense: A review of experimental data and developing ideas on sense-antisense peptide recognition. J. Mol. Recogn. 5, 43-54.
94. VAUGHN, M. K., JOHNSON, L. Y., BLASK, D. E., BRAINARD, G. C., DINH, D. T., PETTERBORG, L. J. & REITER, R. J. (1980). Effect of synthetic therohylseryllysine (TSL), a proposed pineal peptide, on a reproductive organ weights and plasma and pituitary levels of LH, FSH, and prolactin in intact and castrated immature and adult male rodents. Neuroendocr. Lett. 2, 235-240.
95. WALTER, R. (ed.) (1975). Neurophysins: Carriers of Peptide Hormones. New York: New York Academy of Sciences.
96. WEIGENT, D. A., CLARKE, B. L. & BLALOCK, J. E. (1994). Peptide design using a genetically patterned binary code: growth hormone-releasing hormone as a model. Immunomethods 5, 91-97.
97. WEIST, S. A., GESELLCHEM, P. D., ZIMMERMAN, K. & STEINBERG, M. I. (1990). Binding and pharmacologic properties of peptidos derived from human and rat angiotensin II (AII) mRNA. Biochem. Biophys. Res. Commun. 170, 462-469.